ZY19489

· Zydus Lifesciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZY19489, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers [Phase 1]

See pricing